Published in Law and Health Weekly, January 26th, 2008
Follow the money for this study: tort reform group Pacific Research Institute (PRI) funds CMPI, which shares an executive with a PR firm that represents major pharmaceutical manufacturers. It's no surprise that the big drug-makers are trying to buy studies to avoid responsibility for their drugs that have harmed people.
The sham study even tries to take down an article in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.